Literature DB >> 31773101

SPECIFIC MOLECULAR RECOGNITION AS A STRATEGY TO DELINEATE TUMOR MARGIN USING TOPICALLY APPLIED FLUORESCENCE EMBEDDED NANOPARTICLES.

Shawn Barton1, Bo Li1, Michael Siuta1, Janve Vaibhav1, Jessica Song1, Clinton M Holt1, Takumi Tomono2, Masami Ukawa2, Hironori Kumagai3, Etsuo Tobita3, Kevin Wilson1, Shinji Sakuma2, Wellington Pham1,4,5,6,7,8.   

Abstract

The Thomsen-Friedenreich (TF) antigen is a tumor-associated antigen consistently expressed on the apical surface of epithelial-based cancer cells, including pancreatic cancer. In this work, we report the development of multimodal imaging probe, the tripolymer fluorescent nanospheres, whose surface was fabricated with peanut agglutinin (PNA) moieties as TF molecular recognition molecules. Here, we demonstrate that the probe is able to detect TF antigen in human pancreatic cancer tissues and differentiate from normal tissue. What is most noteworthy regarding the probe is its ability to visualize tumor margins defined by epithelial TF antigen expression. Further, in vivo preclinical studies using an orthotopic mouse model of pancreatic cancer suggest the potential use of the nanospheres for laparoscopic imaging of pancreatic cancer tumor margins to enhance surgical resection and improve clinical outcomes.

Entities:  

Year:  2018        PMID: 31773101      PMCID: PMC6879183          DOI: 10.33218/prnano1(3).181009.1

Source DB:  PubMed          Journal:  Precis Nanomed        ISSN: 2639-9431


  35 in total

1.  Image scanning microscopy.

Authors:  Claus B Müller; Jörg Enderlein
Journal:  Phys Rev Lett       Date:  2010-05-10       Impact factor: 9.161

2.  Role of smoking in global and regional cancer epidemiology: current patterns and data needs.

Authors:  Majid Ezzati; S Jane Henley; Alan D Lopez; Michael J Thun
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

Review 3.  Resection margins in pancreatic cancer.

Authors:  C S Verbeke
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

4.  Redefining resection margin status in pancreatic cancer.

Authors:  Caroline S Verbeke; Krishna V Menon
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

5.  Isolation and characterization of a Vicia graminea and Vicia unijuga lectins-binding (Vgu) glycoprotein with Thomsen-Friedenreich (T) activity from human liver metastases of pancreas carcinoma.

Authors:  E Ueno; K Otsuka; T Kudo; S Ohkuma
Journal:  Int J Biochem       Date:  1992-05

6.  Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.

Authors:  Y Cao; P Stosiek; G F Springer; U Karsten
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

7.  Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Authors:  J P Neoptolemos; D D Stocken; J A Dunn; J Almond; H G Beger; P Pederzoli; C Bassi; C Dervenis; L Fernandez-Cruz; F Lacaine; J Buckels; M Deakin; F A Adab; R Sutton; C Imrie; I Ihse; T Tihanyi; A Olah; S Pedrazzoli; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 8.  Diet and cancer.

Authors:  W C Willett
Journal:  Oncologist       Date:  2000

Review 9.  Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.

Authors:  Inka Brockhausen
Journal:  EMBO Rep       Date:  2006-06       Impact factor: 8.807

10.  Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging.

Authors:  Livia S Eberlin; Katherine Margulis; Ivette Planell-Mendez; Richard N Zare; Robert Tibshirani; Teri A Longacre; Moe Jalali; Jeffrey A Norton; George A Poultsides
Journal:  PLoS Med       Date:  2016-08-30       Impact factor: 11.069

View more
  1 in total

Review 1.  Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.

Authors:  Christopher Gromisch; Motaz Qadan; Mariana Albuquerque Machado; Kebin Liu; Yolonda Colson; Mark W Grinstaff
Journal:  Cancer Res       Date:  2020-03-27       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.